CTV News | FDA considers pill to help with sleep deficit

Health -   

FDA considers pill to help with sleep deficit

Viewer

CTV News Video

CTV News: Genevieve Beauchemin reports the FDA may approve a pill for the sleep deprived

Font-size:      Share  Print

CTV.ca News Staff

Date: Sat. Oct. 25 2003 9:40 PM ET

Surveys indicate that Canadians get less than six hours of sleep a night on average, two hours short of the recommended stretch.

What would be a good solution to the sleep deficit -- more sleep, or a pill to help people cope better with lack of sleep?

The U.S. Food and Drug Administration is considering approving for wider use a drug that might help the sleep deprived stay alert and healthy.

Modalfinal was first approved in the 1990s by the FDA and Health Canada for treatment of daytime sleepiness related to narcolepsy.

Modafinil is marketed by Cephalon, Inc. in the United States under the name Provigil. The company is asking the FDA to consider the drug for improving wakefulness in patients with excessive sleepiness associated with shift work sleep disorder, and in patients with obstructive sleep apnea/hypopnea syndrome.

Sleep deprivation can lead to increased risk of diabetes, as well as heart problems and shorter lifespans. But researchers still aren't sure how Modafinil works, and whether it will help with these kinds of effects.

Dr. Diane Boivin, with the psychiatry department at Montreal's Douglas Hospital Research Centre, has looked into shift workers' sleep troubles. She told CTV News that Modafinil is a good drug that could help emergency workers who need to work nights, but it shouldn't be put into general use.

"There's a choice of society to be made and we should try to limit this 24 hour society," Boivin said. "It's still not normal to be up at night."

Shire Biochem sells the drug under the name Alertec in Canada. The company said that for now, it has not filed the paperwork to seek approval for wider use in Canada.

Share with your social Network:

 

Advertisement

Contest

Related Websites

User Tools

About the tools

Need to get in touch with CTV? You can email the CTV web team using the 'Feedback' button.

Share it with your network of friends

Share this CTV article or feature with your friends. Click on the icon for your favourite social networking or messaging system, and follow the prompts.

Share this article with Facebook

Share this article with Digg

Share this article with Newsvine

Share this article with delicious

Share this article.
Send Email

Share this article with Twitter

Share this article with StumbleUpon

Share this article with Reddit

Share this article with Yahoo! Buzz

Most Talked about Stories

The chance of the destruction of our planet is very very small with this collider, but who are these people to decide what risks are acceptable for all of mankind? It puts me at unease and adds to my anxiety. CERN acknowledges that there are miniscule risks -- they admit to it so please spare the convoluted retorts.

kc-bby

Hadron Collider back in action after year of repairs